660 related articles for article (PubMed ID: 18996161)
41. Complete protection for mice conferred by a DNA vaccine based on the Japanese encephalitis virus P3 strain used to prepare the inactivated vaccine in China.
Zheng X; Yu X; Wang Y; Turtle L; Cui M; Wang R; Yin C
Virol J; 2020 Aug; 17(1):126. PubMed ID: 32831096
[TBL] [Abstract][Full Text] [Related]
42. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.
Liu X; Yu Y; Li M; Liang G; Wang H; Jia L; Dong G
Vaccine; 2011 Mar; 29(11):2127-30. PubMed ID: 21237278
[TBL] [Abstract][Full Text] [Related]
43. Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells.
Appaiahgari MB; Vrati S
Vaccine; 2004 Sep; 22(27-28):3669-75. PubMed ID: 15315846
[TBL] [Abstract][Full Text] [Related]
44. Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model.
Ashok MS; Rangarajan PN
Vaccine; 2002 Feb; 20(11-12):1563-70. PubMed ID: 11858863
[TBL] [Abstract][Full Text] [Related]
45. Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination.
Gao N; Chen W; Zheng Q; Fan DY; Zhang JL; Chen H; Gao GF; Zhou DS; An J
Immunol Lett; 2010 Mar; 129(1):23-31. PubMed ID: 20064558
[TBL] [Abstract][Full Text] [Related]
46. Immunogenicity of a Japanese encephalitis DNA vaccine candidate in cynomolgus monkeys.
Tanabayashi K; Mukai R; Yamada A; Takasaki T; Kurane I; Yamaoka M; Terazawa A; Konishi E
Vaccine; 2003 Jun; 21(19-20):2338-45. PubMed ID: 12744864
[TBL] [Abstract][Full Text] [Related]
47. Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines.
Abe M; Shiosaki K; Hammar L; Sonoda K; Xing L; Kuzuhara S; Kino Y; Holland Cheng R
Virus Res; 2006 Nov; 121(2):152-60. PubMed ID: 16815584
[TBL] [Abstract][Full Text] [Related]
48. Modulation of immune responses by the antimicrobial peptide, epinecidin (Epi)-1, and establishment of an Epi-1-based inactivated vaccine.
Huang HN; Pan CY; Rajanbabu V; Chan YL; Wu CJ; Chen JY
Biomaterials; 2011 May; 32(14):3627-36. PubMed ID: 21316756
[TBL] [Abstract][Full Text] [Related]
49. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW
Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299
[TBL] [Abstract][Full Text] [Related]
50. Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus.
Lin CW; Liu KT; Huang HD; Chen WJ
Biotechnol Lett; 2008 Feb; 30(2):205-14. PubMed ID: 17876533
[TBL] [Abstract][Full Text] [Related]
51. Enhancement of autophagy as a strategy for development of new DNA vaccine candidates against Japanese encephalitis.
Zhao F; Zhai Y; Zhu J; Xiao P; Feng G
Vaccine; 2019 Sep; 37(37):5588-5595. PubMed ID: 31399273
[TBL] [Abstract][Full Text] [Related]
52. Characterization of immune responses induced by inactivated, live attenuated and DNA vaccines against Japanese encephalitis virus in mice.
Li J; Chen H; Wu N; Fan D; Liang G; Gao N; An J
Vaccine; 2013 Aug; 31(38):4136-42. PubMed ID: 23845821
[TBL] [Abstract][Full Text] [Related]
53. Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles.
Konishi E; Fujii A; Mason PW
J Virol; 2001 Mar; 75(5):2204-12. PubMed ID: 11160724
[TBL] [Abstract][Full Text] [Related]
54. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
[TBL] [Abstract][Full Text] [Related]
55. Intramuscular immunization with a plasmid DNA vaccine encoding prM-E protein from Japanese encephalitis virus: enhanced immunogenicity by co-administration of GM-CSF gene and genetic fusions of prM-E protein and GM-CSF.
Zhai YZ; Li XM; Zhou Y; Ma L; Feng GH
Intervirology; 2009; 52(3):152-63. PubMed ID: 19521104
[TBL] [Abstract][Full Text] [Related]
56. Sub-fragments of the envelope gene are highly protective against the Japanese encephalitis virus lethal infection in DNA priming--protein boosting immunization strategies.
Wu HH; Chen CT; Lin YL; Lee ST
Vaccine; 2004 Jan; 22(5-6):793-800. PubMed ID: 14741175
[TBL] [Abstract][Full Text] [Related]
57. Enhancement of humoral and cellular immunity in mice against Japanese encephalitis virus using a DNA prime-protein boost vaccine strategy.
Li P; Cao RB; Zheng QS; Liu JJ; Li Y; Wang EX; Li F; Chen PY
Vet J; 2010 Feb; 183(2):210-6. PubMed ID: 19008134
[TBL] [Abstract][Full Text] [Related]
58. Design and characterization of polytope construct with multiple B and TH epitopes of Japanese encephalitis virus.
Kulkarni R; Sapkal G; Mahishi L; Shil P; Gore MM
Virus Res; 2012 Jun; 166(1-2):77-86. PubMed ID: 22445688
[TBL] [Abstract][Full Text] [Related]
59. Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine.
Wu CJ; Huang HW; Tao MH
Vaccine; 2003 Sep; 21(25-26):3938-45. PubMed ID: 12922129
[TBL] [Abstract][Full Text] [Related]
60. Foot-and-Mouth Disease Virus neutralizing antibodies production induced by pcDNA3 and Sindbis virus based plasmid encoding FMDV P1-2A3C3D in swine.
Dory D; Rémond M; Béven V; Cariolet R; Zientara S; Jestin A
Antiviral Res; 2009 Jul; 83(1):45-52. PubMed ID: 19501256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
